Skip to content
Trial Eligibility
Menu

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

NCT06801834

This study is recruiting at 20 US sites in 12 states, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this clinical study is to learn more about the study drug sacituzumab govitecan (SG; Trodelvy®; GS-0132; IMMU 132), versus standard of care (SOC) in participants with previously treated extensive stage small cell lung cancer (ES-SCLC). The primary objectives of this study are to compare the effect of SG to SOC on overall survival (OS).

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Eligibility basics and study details

Study type
Interventional
Phase
Phase 3
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Gilead Sciences
Last updated on ClinicalTrials.gov
August 12, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Alaska · 1

  • Alaska Oncology and Hematology · Anchorage, AK

Arkansas · 1

  • Genesis Cancer and Blood Institute · Hot Springs, AR

California · 1

  • Los Angeles Cancer Network · Anaheim, CA

Florida · 1

  • Boca Raton Regional · Miami, FL

Illinois · 3

  • Hope and Healing Cancer Services · Hinsdale, IL
  • Southern Illinois University School of Medicine · Springfield, IL
  • Springfield Clinic · Springfield, IL

Indiana · 2

  • Parkview Research Center · Fort Wayne, IN
  • IU Health Ball Memorial Hospital and Physicians - Cancer Center - Muncie · Muncie, IN

Kentucky · 2

  • Northwest Cancer Centers · Dyer, KY
  • St. Claire Regional Medical Ce · Morehead, KY

New Mexico · 1

  • New Mexico Oncology Hematology Consultants, Ltd · Albuquerque, NM

Ohio · 2

  • University Hospitals Seidman Cancer Center · Sandusky, OH
  • Taylor Cancer Research Foundation · Toledo, OH

Pennsylvania · 1

  • Spoknwrd Clinical Trials Inc. · Easton, PA

Texas · 4

  • Hendrick Health System · Abilene, TX
  • MD Anderson Cancer Center · Houston, TX
  • Texas Oncology - San Antonio · New Braunfels, TX
  • The University of Texas Health Science Center at Tyler · Tyler, TX

Wisconsin · 1

  • Gundersen Health System · West Salem, WI

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.